The overall aim of this proposal is to better understand the cellular and molecular underpinnings of terminal erythroid cell maturation. Our red cell mass is sustained by a robust process of cell maturation that is primarily dependent on the hormone erythropoietin (EPO). EPO, signaling through its cognate receptor (EPOR) provides a critical survival signal to late-stage definitive erythroid progenitors making it difficult to study its role in the downstream terminal maturation o erythroid precursors. While EPO is widely recognized to be essential for definitive erythropoiesis, its role in primitive erythropoiesis, a transient lineage necessary for embryonic growth and survival, remains controversial and poorly understood. We hypothesize that EPO plays a central role in the terminal maturation of the primitive erythroid lineage. This hypothesis will be tested in Aim 1 studies by delineating the role of EPO in mouse embryos lacking EPOR as well as in an ex vivo 2-step primitive erythroid culture system. Our recent studies of radiation injury to the bone marrow have led us to hypothesize that terminal erythroid cell maturation is characterized by a transition from a pro-apoptotic to an anti-apoptotic state (Peslak, 2011). Preliminary studies indicate that EPO prevents the apoptosis of late-stage primitive erythroid precursors. The persistence of mutant primitive erythroid cells in EPOR-null embryos provides a unique opportunity to investigate the role of EPO in terminal stages of erythroid cell maturation. We have identified pro- and anti-apoptotic genes whose levels are dramatically altered by loss of EPO.
In Aim 2, we will more fully characterize the expression of pro- and anti-apoptotic genes in wild-type and EPOR-null erythroblasts. Furthermore, we will delineate the role of Stat signaling in the regulation of Bcl-xL both in wild- type and in mutant primitive erythroblasts lacking Stat5 signaling. Our studies of EPO function in late stages of erythroid maturation may ultimately provide insights, by comparison, into the role of this clinically important cytokine in EPO-responsive non-erythroid cells, both normal and malignant.
Anemia is a widespread problem afflicting more than 2 billion people worldwide. The hormone erythropoietin is the main driver of red blood cell production in our bodies. The goal of this research is to better understand the role of erythropoietin in the final stages of maturation by studying a unique embryonic red blood cell lineage.
|Liddicoat, Brian J; Hartner, Jochen C; Piskol, Robert et al. (2016) Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis. Exp Hematol 44:947-63|
|Gnanapragasam, Merlin Nithya; McGrath, Kathleen E; Catherman, Seana et al. (2016) EKLF/KLF1-regulated cell cycle exit is essential for erythroblast enucleation. Blood 128:1631-41|
|Palis, James (2014) Primitive and definitive erythropoiesis in mammals. Front Physiol 5:3|
|Getman, Michael; England, Samantha J; Malik, Jeffery et al. (2014) Extensively self-renewing erythroblasts derived from transgenic Î²-yac mice is a novel model system for studying globin switching and erythroid maturation. Exp Hematol 42:536-46.e8|
|Malik, Jeffrey; Kim, Ah Ram; Tyre, Kaitlin A et al. (2013) Erythropoietin critically regulates the terminal maturation of murine and human primitive erythroblasts. Haematologica 98:1778-87|
|Greenfest-Allen, Emily; Malik, Jeffrey; Palis, James et al. (2013) Stat and interferon genes identified by network analysis differentially regulate primitive and definitive erythropoiesis. BMC Syst Biol 7:38|